Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.

Sullivan R, Paré GC, Frederiksen LJ, Semenza GL, Graham CH.

Mol Cancer Ther. 2008 Jul;7(7):1961-73. doi: 10.1158/1535-7163.MCT-08-0198.

2.

Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide.

Siemens DR, Hu N, Sheikhi AK, Chung E, Frederiksen LJ, Pross H, Graham CH.

Cancer Res. 2008 Jun 15;68(12):4746-53. doi: 10.1158/0008-5472.CAN-08-0054.

3.

Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.

Frederiksen LJ, Sullivan R, Maxwell LR, Macdonald-Goodfellow SK, Adams MA, Bennett BM, Siemens DR, Graham CH.

Clin Cancer Res. 2007 Apr 1;13(7):2199-206.

4.

Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.

Bell EN, Tse MY, Frederiksen LJ, Gardhouse A, Pang SC, Graham CH, Siemens DR.

J Urol. 2007 Feb;177(2):751-6.

PMID:
17222675
5.

Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate.

Frederiksen LJ, Siemens DR, Heaton JP, Maxwell LR, Adams MA, Graham CH.

J Urol. 2003 Sep;170(3):1003-7.

PMID:
12913759

Supplemental Content

Loading ...
Support Center